{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T16:59:16Z","timestamp":1782493156413,"version":"3.54.5"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,12]]},"abstract":"<jats:p>Distinguishing lupus erythematosus panniculitis (LEP) from subcutaneous panniculitis-like T-cell lymphoma (SPTCL) is a diagnostic challenge with important clinical implications. Immunohistochemical expression of interferon regulatory factor 8 (IRF8) has been shown to highlight cells with plasmacytoid dendritic cell differentiation. Considering that the presence of plasmacytoid dendritic cells highlighted by CD123 immunolabeling is a well-described feature that supports LEP over SPTCL, we hypothesized that IRF8 immunohistochemistry can be used as a diagnostic test to improve accuracy in differentiating LEP from SPTCL. In this study, we assessed the expression of IRF8, CD123, and CD20 in 35 cutaneous biopsies from 31 distinct patients, which included 22 cases of LEP and 13 cases of SPTCL. We found that clusters of IRF8-positive cells within the dermis, and away from subcutaneous fat, could discriminate LEP from SPTCL (<jats:italic toggle=\"yes\">P<\/jats:italic>=0.005). Similarly, CD123-positive clusters in any location were observed in LEP but absent in all cases of SPTCL. In addition, we found that dermal CD20-predominant lymphoid aggregates could help discriminate LEP from SPTCL (<jats:italic toggle=\"yes\">P<\/jats:italic>=0.022). As individual assays, IRF8, CD123, and CD20 were highly specific (100%, 100%, and 92%, respectively) though poorly sensitive (45%, 29%, and 50%, respectively). However, a panel combining IRF8, CD123, and CD20, with at least 1 positive marker was more accurate than any individual marker by receiver operating characteristic curve analysis. Our study provides a rationale for potentially including IRF8 as part of an immunohistochemical panel composed of other currently available markers used to differentiate LEP from SPTCL.<\/jats:p>","DOI":"10.1097\/pas.0000000000002133","type":"journal-article","created":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T13:00:08Z","timestamp":1695906008000},"page":"1425-1431","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["IRF8 in Conjunction With CD123 and CD20 to Distinguish Lupus Erythematosus Panniculitis From Subcutaneous Panniculitis-like T-Cell Lymphoma"],"prefix":"10.1097","volume":"47","author":[{"given":"Jahg","family":"Wong","sequence":"first","affiliation":[{"name":"Department of Pathology, University of Montreal Hospital Center, University of Montreal Faculty of Medicine, Montreal, QC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon F.","family":"Roy","sequence":"additional","affiliation":[{"name":"Dermatology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer M.","family":"McNiff","sequence":"additional","affiliation":[{"name":"Dermatology"},{"name":"Pathology, Yale New Haven Hospital, Yale School of Medicine, New Haven, CT"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mina L.","family":"Xu","sequence":"additional","affiliation":[{"name":"Pathology, Yale New Haven Hospital, Yale School of Medicine, New Haven, CT"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,9,28]]},"reference":[{"key":"R1-20250608","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1001\/jamadermatol.2020.2797","article-title":"Clinical characteristics of lupus erythematosus panniculitis\/profundus: a retrospective review of 61 patients","volume":"156","author":"Rangel","year":"2020","journal-title":"JAMA Dermatol"},{"key":"R2-20250608","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1001\/jamadermatol.2022.3347","article-title":"Clinical and pathological characteristics and outcomes among patients with subcutaneous panniculitis-like T-cell lymphoma and related adipotropic lymphoproliferative disorders","volume":"158","author":"Guitart","year":"2022","journal-title":"JAMA Dermatol"},{"key":"R3-20250608","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/PAS.0000000000000307","article-title":"Lobular panniculitic infiltrates with overlapping histopathologic features of lupus panniculitis (lupus profundus) and subcutaneous T-cell lymphoma: a conceptual and practical dilemma","volume":"39","author":"Bosisio","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"R4-20250608","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1097\/DAD.0b013e3181a84f32","article-title":"Subcutaneous panniculitis-like T-cell lymphoma with overlapping clinicopathologic features of lupus erythematosus: coexistence of 2 entities","volume":"31","author":"Pincus","year":"2009","journal-title":"Am J Dermatopathol"},{"key":"R5-20250608","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1034\/j.1600-0560.2001.028005235.x","article-title":"Lupus profundus, indeterminate lymphocytic lobular panniculitis and subcutaneous T-cell lymphoma: a spectrum of subcuticular T-cell lymphoid dyscrasia","volume":"28","author":"Magro","year":"2001","journal-title":"J Cutan Pathol"},{"key":"R6-20250608","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s12308-012-0145-9","article-title":"Clonality testing of cutaneous lymphoid infiltrates: practicalities, pitfalls and potential uses","volume":"5","author":"Sproul","year":"2012","journal-title":"J Hematop"},{"key":"R7-20250608","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1084\/jem.20132522","article-title":"Genetic evidence for the role of plasmacytoid dendritic cells in systemic lupus erythematosus","volume":"211","author":"Sisirak","year":"2014","journal-title":"J Exp Med"},{"key":"R8-20250608","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1111\/j.1600-0560.2010.01587.x","article-title":"Plasmacytoid dendritic cells: an overview of their presence and distribution in different inflammatory skin diseases, with special emphasis on Jessner\u2019s lymphocytic infiltrate of the skin and cutaneous lupus erythematosus","volume":"37","author":"Tomasini","year":"2010","journal-title":"J Cutan Pathol"},{"key":"R9-20250608","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/j.1600-0560.2007.00848.x","article-title":"Plasmacytoid dendritic cells are present in cutaneous dermatomyositis lesions in a pattern distinct from lupus erythematosus","volume":"35","author":"McNiff","year":"2008","journal-title":"J Cutan Pathol"},{"key":"R10-20250608","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1097\/DAD.0000000000001173","article-title":"Subcutaneous panniculitis-like T-cell lymphoma versus lupus erythematosus panniculitis: distinction by means of the periadipocytic cell proliferation index","volume":"40","author":"Sitthinamsuwan","year":"2018","journal-title":"Am J Dermatopathol"},{"key":"R11-20250608","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1097\/PAS.0000000000000596","article-title":"Useful parameters for distinguishing subcutaneous panniculitis-like T-cell lymphoma from lupus erythematosus panniculitis","volume":"40","author":"LeBlanc","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"R12-20250608","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1111\/his.13817","article-title":"Utility of CD123 immunohistochemistry in differentiating lupus erythematosus from cutaneous T cell lymphoma","volume":"74","author":"Chen","year":"2019","journal-title":"Histopathology"},{"key":"R13-20250608","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1111\/his.12105","article-title":"The presence of clusters of plasmacytoid dendritic cells is a helpful feature for differentiating lupus panniculitis from subcutaneous panniculitis-like T-cell lymphoma","volume":"62","author":"Liau","year":"2013","journal-title":"Histopathology"},{"key":"R14-20250608","doi-asserted-by":"crossref","first-page":"353.e8","DOI":"10.1016\/j.immuni.2020.07.003","article-title":"Differential IRF8 transcription factor requirement defines two pathways of dendritic cell development in humans","volume":"53","author":"Cytlak","year":"2020","journal-title":"Immunity"},{"key":"R15-20250608","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1056\/NEJMoa1100066","article-title":"IRF8 mutations and human dendritic-cell immunodeficiency","volume":"365","author":"Hambleton","year":"2011","journal-title":"N Engl J Med"},{"key":"R16-20250608","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1182\/blood-2014-04-570879","article-title":"Functional characterization of the human dendritic cell immunodeficiency associated with the IRF8(K108E) mutation","volume":"124","author":"Salem","year":"2014","journal-title":"Blood"},{"key":"R17-20250608","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1097\/PAS.0000000000001765","article-title":"IRF8 is a reliable monoblast marker for acute monocytic leukemias","volume":"45","author":"Katz","year":"2021","journal-title":"Am J Surg Pathol"},{"key":"R18-20250608","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.humpath.2022.01.004","article-title":"Global assessment of IRF8 as a novel cancer biomarker","volume":"122","author":"McQuaid","year":"2022","journal-title":"Hum Pathol"},{"key":"R19-20250608","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1097\/PAS.0000000000001874","article-title":"IRF8 is a reliable monoblast marker for acute monocytic leukemias, but does not discriminate between monoblasts and plasmacytoid dendritic cells","volume":"46","author":"Tzankov","year":"2022","journal-title":"Am J Surg Pathol"},{"key":"R21-20250608","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th Edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"key":"R22-20250608","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1182\/blood.2022015851","article-title":"The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee","volume":"140","author":"Campo","year":"2022","journal-title":"Blood"},{"key":"R23-20250608","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1034\/j.1600-0560.2001.280101.x","article-title":"The cutaneous pathology of lupus erythematosus: a review","volume":"28","author":"Crowson","year":"2001","journal-title":"J Cutan Pathol"},{"key":"R24-20250608","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1182\/blood-2007-04-087288","article-title":"Subcutaneous panniculitis-like T-cell lymphoma: definition, classification, and prognostic factors: an EORTC Cutaneous Lymphoma Group Study of 83 cases","volume":"111","author":"Willemze","year":"2008","journal-title":"Blood"},{"key":"R25-20250608","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1309\/AJCPO4DS0GTLSOEI","article-title":"Distinct expression patterns of CD123 and CD34 on normal bone marrow B-cell precursors (\u201chematogones\u201d) and B lymphoblastic leukemia blasts","volume":"132","author":"Hassanein","year":"2009","journal-title":"Am J Clin Pathol"},{"key":"R26-20250608","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1097\/PAS.0000000000001316","article-title":"Dual expression of TCF4 and CD123 is highly sensitive and specific for blastic plasmacytoid dendritic cell neoplasm","volume":"43","author":"Sukswai","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"R27-20250608","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/labinvest.2015.138","article-title":"Loss of antigenicity with tissue age in breast cancer","volume":"96","author":"Combs","year":"2016","journal-title":"Lab Invest"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002133","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,8]],"date-time":"2025-06-08T20:02:33Z","timestamp":1749412953000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002133"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,28]]},"references-count":26,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000002133","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9,28]]}}}